An antimicrobial stewardship program can prevent antibiotic resistance and deliver correct antimicrobials with fast, accurate diagnosis tools from Henry Schein.
The goal of antimicrobial stewardship programs (ASPs) is to aid physicians in avoiding unnecessary antimicrobial use while providing optimal antimicrobial therapy to their patients—prescribing the right antimicrobial regimen to the right patient for the right period of time.
Diagnostic testing is one key initiative identified by the Obama administration's National Action Plan for Combating Antibiotic-Resistant Bacteria to combat the rise of antibiotic-resistant bacteria:1
The FDA has issued new minimum clinical performance criteria for rapid influenza virus antigen detection test systems (RIDTs) that became effective on January 12, 2018. RIDTs are now regulated as class II devices, a higher-risk designation. This is intended to improve the quality of testing for influenza. In line with antimicrobial stewardship guidelines that promote fast and accurate diagnoses, these new minimum performance requirements are expected to lower the amount of misdiagnosed flu infections by increasing the reliability of influenza virus detecting devices.
Henry Schein offers cutting-edge tools that quickly test and confirm your diagnosis to ensure you'll use the correct antimicrobial—or no antimicrobial—for the condition.
This test provides a simple, rapid method to aid in the diagnosis of strep A using nasal swab specimens. The product is CLIA-waived and has canister packaging for ease of multiple testing.
Product Details & Ordering
This cassette test provides a simple, rapid method to aid in the diagnosis of strep A. The product is CLIA-waived and offers an easy-to-use flip design and all-in-one extraction, incubation, and test. Results are available in 5–10 minutes, with sensitivity of 96.2% and specificity of 98.7%. External negative and positive controls included.
Alere™ i is a rapid, instrument-based, isothermal system for the qualitative detection of infectious diseases. Its unique isothermal nucleic acid amplification technology provides molecular results in just minutes, allowing you to make effective clinical decisions sooner. The Alere™ i is part of the company's Test Target Treat™ initiative for antimicrobial stewardship.
Sofia 2 is a small benchtop analyzer that uses advanced fluorescence detection with an ultraviolet LED energy source. It collects hundreds of data points on the test strip contained inside of a Sofia FIA Test Cassette. Using proprietary algorithms, it analyzes the data, interprets the signals, and automatically determines the results.
The BD Veritor™ Plus system provides objective, lab-quality immunoassay test results—within minutes. The system streamlines the point-of-care diagnostic workflow, allowing providers to quickly review patient results and determine the appropriate treatment in a single consultation. It can help detect infectious diseases such as influenza A and B, respiratory syncytial virus (RSV), and group A strep while the patient is on site, which may facilitate decision-making for earlier intervention.
The Solana Influenza A+B Assay is a rapid qualitative in vitro diagnostic test for the detection and differentiation of influenza A and influenza B viral RNA in nasal and nasopharyngeal swabs from patients with signs and symptoms of respiratory infection.
The cobas® Liat System is a compact, innovative real-time polymerase chain reaction (PCR) platform designed for on-demand STAT testing at the point of care or in the laboratory, to support time-sensitive diagnoses and treatment decisions. All nucleic acid testing processes are fully automated, including sample preparation, amplification and real-time detection. Each Liat assay tube contains all assay reagents for a single test, prepared in isolated segments—add nothing but your patient sample.
Cepheid products carrying the Xpress mark feature next-generation test design and cartridge innovations for best-in-class workflow and dramatically faster results. The brand promises rapid testing with ease-of-use, quality, and accuracy.
Learn more about Antimicrobial stewardship tools to promote appropriate antimicrobial (antibiotics) use, to reduce microbial resistance and decrease the spread of infections.